论文部分内容阅读
一场使三株公众形象受到极大损害的官司——湖南常德陈然之诉讼案,3月25日经湖南省高级人民法院二审判决,三株公司胜诉。诉讼结果表明陈伯顺老人的死亡与三株口服液没有关系,三株口服液是有益于人体健康的合格保健药品。 1998年3月,常德市中级人民法院在此案一审过程中,作出了陈伯顺老人因服用三株口服液致死的判决。三株公司不服,上诉至湖南省高级人民法院。湖南省高级人民法院判定,原审判决认定事实,适用法律错误,应予改判。他们依照《中华人民共和国民事诉讼法》第153条1款(二)项之规定,经高院
A lawsuit that greatly damaged the public image of the three - the lawsuit filed by Chen Ran in Hunan Changde - was passed by the Second Instance of Hunan Higher People’s Court on March 25, winning three suits. The result of the lawsuit shows that the death of Chen Bosun’s elderly is irrelevant to the three oral liquids, and the three oral liquids are qualified health-care drugs that are beneficial to human health. In March 1998, during the first instance of this case, the Intermediate People’s Court of Changde City made a judgment on the death of Chen Bosun’s elder who took three oral liquids. Three companies refused to accept the appeal to the Hunan Provincial Higher People’s Court. The Higher People’s Court of Hunan Province has ruled that if the original judgment of the first instance finds the fact that the applicable law is wrong, it shall be subject to revision. They are in accordance with the provisions of Paragraph 1 (b) of Article 153 of the Civil Procedure Law of the People’s Republic of China,